بحث بسيط
السجلات المعروضة 1 -- 1 من 1
Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes
(
John Wiley and Sons Inc
, 2023 , Article)
Immune therapeutics holds great promise in the treatment of type 1 diabetes (T1D). Nonetheless, their progress is hampered by limited efficacy, equipoise, or issues of safety. To address this, a novel and specific nanodelivery ...